共 144 条
[1]
Siegel R(2014)Cancer statistics, 2014 CA Cancer J Clin 64 9-29
[2]
Ma J(2009)Duration of chemotherapy for advanced non-small-cell lung cancer: a systematic review and meta-analysis of randomized trials J Clin Oncol 27 3277-3283
[3]
Zou Z(2003)Altered protein kinase C (PKC) isoforms in non-small cell lung cancer cells: PKCdelta promotes cellular survival and chemotherapeutic resistance Cancer Res 63 780-786
[4]
Jemal A(2007)Classical PKC isoforms in cancer Pharmacol Res 55 477-486
[5]
Soon YY(2003)A phase II study of bryostatin-1 and paclitaxel in patients with advanced non-small cell lung cancer Lung Cancer 39 191-196
[6]
Stockler MR(2007)Phase I and pharmacokinetic study of 7-hydroxystaurosporine and carboplatin in advanced solid tumors Clin Cancer Res 13 2667-2674
[7]
Askie LM(2003)Cell cycle-dependent potentiation of cisplatin by UCN-01 in non-small-cell lung carcinoma Cancer Chemother Pharmacol 51 337-348
[8]
Boyer MJ(2004)Phase I study of PKC412 (N-benzoyl-staurosporine), a novel oral protein kinase C inhibitor, combined with gemcitabine and cisplatin in patients with non-small-cell lung cancer Ann Oncol 15 316-323
[9]
Clark AS(2005)Randomized phase II evaluation of aprinocarsen in combination with gemcitabine and cisplatin for patients with advanced/metastatic non-small cell lung cancer Invest New Drugs 23 263-269
[10]
West KA(2010)Randomized, phase II trial of pemetrexed and carboplatin with or without enzastaurin versus docetaxel and carboplatin as first-line treatment of patients with stage IIIB/IV non-small-cell lung cancer J Thorac Oncol 5 1963-1969